1 min read|59 words
๐จ Breaking Newsvia FDA Safety Alerts
AUBURN, Ala. (August 21, 2026) โ Vitruvias Therapeutics, Inc. is voluntarily recalling one lot (Lot. No. 504950) of Thyroid Tablets, USP 30 mg to the consumer level. The product is being recalled because testing confirmed the potential for the product to be superpotent.
This is a developing story.
Source: Vitruvias Therapeutics, Inc Issues Nationwide Recall of One Lot ofโฆ
Was this article helpful?

